Cabazitaxel oral (Modra Pharmaceuticals)

卡巴他赛口服制剂 (Modra Pharmaceuticals)

Report date: 2025/07/17 10:41:50

Base Information

Drug NameCabazitaxel oral (Modra Pharmaceuticals)
Drug Alias NameModraCab001/r
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesModra Pharmaceuticals Bv
China Registration ClassN/A

Develop Information

Active CompaniesModra Pharmaceuticals Bv
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A